Answers are grounded in this paper and cite their sources.
, and were found to survive in ischemic muscle for up to 4 weeks dependent on cell dose and injection frequency. In addition, double high dose and low dose of MSC injections increased vessel formation, and decreased fibrosis volumes and apoptotic cell numbers, whereas a single high dose did not. Our results showed MSCs protect against ischemic injury in a paracrine manner, and suggest that increasing injection frequency is more important than MSC dosage for the treatment CLI.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: